A Study to Assess the Efficacy and Tolerance of HRS-2261 in Subjects With Refractory Chronic Cough
Clinical trial NCT05733533 · COMPLETED
Trial details
- NCT number
- NCT05733533
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-09
- Primary completion
- 2024-03-05
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.